News

Deaths from dementia up nearly 70pc in a decade

Dementia remains Australia’s second leading overall cause of death for the fourth year in a row and leading cause of death for women, according to the ‘2018 Causes of Death Report’ released last month by the Australian Bureau of Statistics. The number of deaths from dementia has reportedly increased by …

Read More »

Downside of codeine upscheduling hailed

The TGA’s upscheduling of codeine has produced a welcome downside, with researchers describing “a massive and abrupt reduction in codeine poisonings”, and data revealing codeine sales have halved. This week, researchers from the University of Sydney published the first peer-reviewed research to examine the short-term implications of the February 2018 …

Read More »

TerryWhite Chemmart reveals 2020 plans at annual supplier forum

TerryWhite Chemmart has shared its progress in differentiating customer and network partner offers with 300 of its suppliers at its network partner conference at the Gold Coast. A focus on stronger execution, and a compelling brand campaign with That’s Real Chemistry has led to strong transaction and sales growth since …

Read More »

Webstercare’s six-pak for Parkinson’s patients

People living with Parkinson’s disease will be able to better manage the need for increased medication frequency and on-time dosing intervals with this week’s launch of the Webstercare Parkinson’s 6 Dose Webster-Pak. While standard Webster-paks allow for medication to be taken four times a day, the new Parkinson’s 6 Dose …

Read More »

NCI centres team with GenesisCare network

Cancer treatment specialist GenesisCare has partnered with Northern Cancer Institute (NCI), which provides medical oncology and haematology at two locations in northern Sydney. The partnership will involve the two NCI cancer centres at St Leonards and Frenchs Forest joining GenesisCare’s international oncology network. GenesisCare CEO Dan Collins says patients have …

Read More »

Australian mental health prize finalists

Seven finalists have been selected for the 2019 Australian Mental Health Prize. The prize, now in its fourth year, recognises Australians who have made outstanding contributions to the promotion of mental health or the prevention and treatment of mental illness. This year’s winner will be announced at a mental health …

Read More »

Limit your salt shaker

The World Hypertension League and other international health organisations have called for tobacco-style health warnings to be placed on salt sold in supermarkets and on saltshakers in restaurants. This comes in response to a position statement published in the Journal of Clinical Hypertension, whose lead author and former President of …

Read More »

New PBS listing to treat lung cancer

In an Australian-first, an immunotherapy, anti-angiogenic and chemotherapy combination will be listed on the Pharmaceutical Benefits Scheme on October 1, 2019 for the treatment of metastatic non-small cell lung cancer (NSCLC). Atezolizumab (sold as Tecentriq) and bevacizumab (sold as Avastin) and a platinum-doublet chemotherapy will be reimbursed for the first-line …

Read More »

Kisqali a cancer treatment option for younger women

Aromatase inhibitor (AI), Kisqali, a CDK4/6 inhibitor has received a specific indication from the Therapeutic Goods Administration (TGA) for use in pre-/peri-menopausal Australian women with advanced metastatic HR+/HER2-breast cancer. This is said to be supported by significant overall survival data from the study, MONALEESA-7. MONALEESA-7 has reportedly demonstrated Kisqali significantly …

Read More »